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ABSTRACT: We report a detailed study of a promising photo-
activatable metal-based anticancer prodrug candidate, trans,trans,-
trans-[Pt(N3)2(OH)2(py)2] (C1; py = pyridine), using vibrational
spectroscopic techniques. Attenuated total reﬂection Fourier trans-
form infrared (ATR-FTIR), Raman, and synchrotron radiation far-IR
(SR-FIR) spectroscopies were applied to obtain highly resolved
ligand and Pt-ligand vibrations for C1 and its precursors (trans-
[Pt(N3)2(py)2] (C2) and trans-[PtCl2(py)2] (C3)). Distinct IR- and
Raman-active vibrational modes were assigned with the aid of density
functional theory calculations, and trends in the frequency shifts as a
function of changing Pt coordination environment were determined
and detailed for the ﬁrst time. The data provide the ligand and
Pt-ligand (azide, hydroxide, pyridine) vibrational signatures for C1 in the mid- and far-IR region, which will provide a basis for
the better understanding of the interaction of C1 with biomolecules.
■ INTRODUCTION
Cancer chemotherapy is landmarked by the indisputable clinical
success of cisplatin,1−3 with ca. 50% of all the cancer patients
receiving a platinum compound.4 Disappointingly, however,
platinum therapy suﬀers from several drawbacks, which include
acquired resistance, limited spectrum of activity, and toxic
side eﬀects.5−7 Consequently, constant eﬀorts are being made
to develop new generations of metallo-pharmaceuticals that
address these shortcomings, including the design of less toxic
Pt(IV) prodrugs, which are activated in cancer cells either by
(bio)chemical or photoinduced reduction.8−19
Localized treatment of cancer by light builds upon the
clinically established photodynamic therapy (PDT), which
produces highly reactive singlet oxygen species (1O2) by energy
transfer from light to photosensitizers and subsequently to
ground-state triplet oxygen (3O2). However, PDT relies on the
presence of oxygen at the targeted treatment site, which is a
major drawback, as many malignant and most aggressive tumors
are hypoxic by nature.20 By contrast, local activation of metal-
based prodrugs by light, also referred to as inorganic photo-
activated chemotherapy (PACT), oﬀers the possibility of oxygen-
independent treatment, where reactive (metal-based) species are
formed upon irradiation.21−28
The trans,trans,trans-[Pt(N3)2(OH)2(py)2] (C1; Figure 1)
species is one such promising inert and nontoxic platinum(IV)
diazido anticancer prodrug candidate for PACT, which can be
locally activated in cancer cells under UV-A and visible light
irradiation while being stable in the dark under biological condi-
tions.10,14,29−31 Upon photoactivation, C1 undergoes changes in
the metal coordination environment, giving rise to Pt(II), nitrene,
and radical photoproducts, as well as cleaved ligands, which act in
concert to elicit the observed multitargeted biological activity;10
irradiation of C1 results in stalling of RNA polymerase II and
an ∼16-fold increase in DNA “platination” compared to cisplatin.32
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Figure 1. Structures of platinum complexes studied in this work:
trans,trans,trans-[Pt(N3)2(OH)2(py)2] (C1), trans-[Pt(N3)2(py)2]
(C2), and trans-[PtCl2(py)2] (C3).
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The exact mechanism of action of C1, however, is not com-
pletely understood.
Vibrational spectroscopic studies of biological samples and
biomolecule−drug interactions constitute a rapidly expanding
research area because of the increase in throughput, improve-
ments in spatial resolution, and availability of methodology to
process large data sets, while at the same time being label-free
and nondestructive.33 Of particular interest to us is the fact
that it allows changes in the metal coordination environment to
be monitored in the mid- and far-IR spectral regions. This can be
extremely useful for studying metal-containing drugs, particularly
those containing functionalities with unique vibrational bands
(e.g., azido, nitrosyl, cyano, and carbonyl groups).
Given that previous eﬀorts to elucidate the mechanism of
actions of C1 have shown that the activity is indeed associated
with changes in metal coordination environment, vibrational
spectroscopy becomes a useful tool to investigate further its
multitargeted biological activity.34−40 Previous mechanistic studies
have revealed that wavelength-dependent photodecomposition of
these Pt(IV) complexes gives rise to Pt-nitrene intermediates,
singlet oxygen, free azide, and azidyl radicals capable of oxidizing
a biomolecular target, 5′-guanosine monophosphate.10,13,14
With its ability to provide functional group analysis, vibrational
spectroscopy can serve to monitor the complex processes
occurring upon irradiation and to assess binding sites of such
metal-based (pro)drug candidates following activation.
Herein, vibrational spectroscopy studies are presented, which
have allowed a detailed assignment of ligand and metal−ligand
vibrational modes for C1, the diazido Pt(IV) anticancer prodrug
candidate, and two of its synthetic Pt(II) precursors, trans-
[Pt(N3)2(py)2] (C2; Figure 1) and trans-[PtCl2(py)2] (C3;
Figure 1). Three vibrational spectroscopic techniques, speciﬁ-
cally, ATR-FTIR, Raman, and synchrotron radiation far-IR
spectroscopy (SR-FIR) were used to assign all the vibrations,
assisted through vibrational mode predictions obtained from
the density functional theory (DFT) calculations on C1−C3.
Although C1 has been subjected to several biological studies,
no vibrational spectroscopic investigations have been conducted
to date. The measured frequency data provide the infrared and
Raman-active vibrational ﬁngerprints for C1, which is an essential
ﬁrst step toward elucidating the complex mechanism of action
and intermolecular interactions of C1 and other such Pt(IV)
(pro)drug candidates using vibrational spectroscopic techniques.
■ RESULTS AND DISCUSSION
Measurements were performed as described in the Experimental
Section. It is important to note that the use of aqueous media
(buﬀers and/or cell media) is preferred when carrying out
in vitro studies aimed at understanding the mechanism of action
such drug candidates. Thus, it is equally important to assign
thoroughly the vibrational ﬁngerprints of C1 after exposure to
such media. For this purpose, dissolution of C1 in water followed
by evaporation (hereafter referred to as C1′) was performed
prior to measuring ATR-FTIR and Raman spectra and compared
to the spectra of crystalline C1. To conﬁrm comparison is
possible between spectra obtained by the diamond and silicon
ATR accessories, 9 μL (diamond) and 3 μL (Si) solutions of
C1 (2 mM) were deposited on the ATR accessories, and no
discernible diﬀerences between the spectra were observed
(Figure S13). Only the silicon ATR results of C1′ are reported
throughout this manuscript.
Ground-state lowest energy (S0) geometries, computed
by theoretical calculations as described in the Experimental
Section, were compared to the previously reported crystal
structures, and closest matches from both PBE (Figure 2) and
M06-2X were used to ﬁt the experimental vibrational
results.10,41,42 Two S0 geometries of lowest energy (Figure 2,
C2−1 and C2−2, ΔE = 3.1 kJ/mol) were used for C2 to
account for the two conformations observed in its crystal
structure.41
Selected bond distances and angles of C1, C2, and C3 and
the computed results are shown in Tables S1−3 of the
Supporting Information. The full assignments for the individual
complexes (Tables S4−S6), Cartesian coordinates of all S0
geometries, calculated IR frequencies, including assignments
and a description of planes (Figure S1) used for vibrational
assignment can also be found in the Supporting Information. The
vibrational modes of pyridine coordinated to platinum are derived
from Wilson’s notation for benzene and are shown in Figure S2
to avoid discrepancies in nomenclature.43 Selected ATR-FTIR,
Raman, SR-FIR, and unscaled theoretical PBE vibrational bands
of C1, C2, and C3 are shown in Table 1 (see Supporting
Information for comments on scaling of vibrational frequencies).
The SR-FIR spectra of C1, C2, and C3 at room temperature
versus 77 K are depicted in Figures S9−S11.
The discussion of the vibrational data for C1−C3 below is
subdivided according to the individual types of ligand vibrations
(pyridine, hydroxido, and azido) and metal−ligand vibrations,
with some suggestions as to how these vibrations could be
monitored to analyze the photodecomposition of C1.
Pyridine Vibrations. Many fundamental vibrational spec-
troscopic studies of pyridine and derivatives thereof have been
reported to date, including for pyridine bound to various
surfaces.45−53 The pyridine vibrations were very well-deﬁned
in the spectra of C1, C2, and C3 and could be readily assigned
(see Table S4−6). These are in agreement with previously
reported results, with the vibrational frequencies shifted relative
to free pyridine in the manner expected.53−55 Selected CH
stretching vibrations, ring deformations, and CH bending
vibrations of pyridine measured by ATR-FTIR are shown in
Figure 3. The spectra clearly demonstrate that a change in the
neighboring ligands, molecular geometry, or crystal packing
does not have a major inﬂuence on the intensities and wave-
number values of the pyridine vibrations, which is in line with
the calculated results.
The medium-to-strong IR and weak Raman bands at 1611 cm−1
(IR and Raman) for C1, 1610 cm−1 (IR)/1611 (Raman) C2
and 1608 cm−1 (IR)/1609 cm−1 (Raman) for C3 are assigned to
the IR- and Raman-active ring stretching mode of pyridine;
δ(py) {A1, 8a}. While this band has been reported as weak in
the Raman spectrum of free pyridine, the trans positioning of
pyridines allows for in-phase bending, which symmetrically
Figure 2. Lowest energy geometries optimized by DFT with PBE
for C1, C3, C2−1, and C2−2. Calculations were performed with
cc-pVDZ for C, H, N, and O and with cc-pVDZ-PP44 with ECP for Pt
using the CPCM with water as solvent.
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C
elongates the Pt−py distances, increasing the Raman cross-
section of this mode.53,55
The position of the fundamental pyridine deformation
vibration, δ(py) {A1, 6a}, has previously been reported to have
a nearly linear relationship with the change in the force constant
of the ligand−metal bond, suggesting that the strength of the
interaction of pyridine and a metal atom (surface) can be gauged
by frequency shifts of this mode.51 In this case, diﬀerences were
observed in the δ(py) vibrations for Pt(IV) and Pt(II), C1/C1′
(660/656 cm−1), and C2/C3 (670/660 cm−1), by ATR-FTIR
only. The Raman spectra did not reveal such a change (662 cm−1
C1, 662 cm−1 C2, and 664 cm−1 C3), and the calculated values
did not predict a signiﬁcant change (640 cm−1 C1, 638 cm−1 C2,
and 639 cm−1 C3).
The SR-FIR spectra show medium-to-strong intensity bands
for the out-of-plane ring deformation γ(py) {B1, 16b} of pyridine
for C1, C2, and C3. Substitution of the chlorido ligands with
azido ligands resulted in a notable shift in band position from
484 cm−1 (C3) to 472 cm−1 (C2), which shifts to 478 cm−1 in
C1, as C2 is subsequently oxidized and two additional hydroxido
ligands are introduced into the Pt(IV) coordination sphere.
In the SR-FIR spectrum at 77 K (Figure 6), two well-deﬁned
lattice vibrations of medium intensity are observed for C3 at
83 and 64 cm−1 and three broader bands of medium-to-weak
intensity for C2 at 83, 59 (sh), and 56 cm−1. In contrast, ﬁve
well-deﬁned lattice vibrations are observed for C1 at 92, 87, 81,
77, and 46 cm−1. Such an increase in the number of lattice modes
is to be expected given the increase in degrees of freedom when
going from square-planar to octahedral geometry. Note that even
though several rotational and translational motions of pyridine
in the matching wavenumber range were predicted by DFT
calculations for C1, C2, and C3 (Supporting Information), we
refrain from assigning them to the experimental data unlike the
other vibrations of higher wavenumber values. Calculated trans-
lational modes are expected to be close to zero (within 10 cm−1)
due to the nature of frequency calculations, whereas rotational
modes need to be treated using higher-level approximations
beyond the harmonic oscillator for meaningful results, which was
outside the scope of this work.
Hydroxido Vibrations. ATR-FTIR and Raman spectra
reveal single hydroxido stretching vibrations, υ(OH), for C1
crystals at 3566 and 3571 cm−1, respectively (Figures S6 and S8).
These bands were matched by the calculated results and are in
accordance with other platinum−hydroxido stretching vibra-
tions.56−60 Upon dissolution of C1 in water, followed by
evaporation, this vibration is reduced by 15 cm−1 by IR and by
11 cm−1 by Raman. The presence of intermolecular hydrogen
bonding observed in the crystal structure between hydroxido
ligands of neighboring complexes is also evident by ATR-FTIR
spectroscopy, as seen by the broad medium band peaking
at ∼3200 cm−1.10
Azido Vibrations. Linear triatomic molecules (D∞h), such
as azide, have four theoretical vibrational modes; asymmetric
and symmetric stretching (υasym(N3), υsym(N3)) and the doubly
degenerate bending vibrations (δ(N3), γ(N3)). Multiple bands
for the asymmetric azido stretch, υasym(N3), are observed by
ATR-FTIR and Raman spectroscopy for both complex C1,
C1′, and C2, which were matched to the calculated vibrations
(Table 1). υasym(N3) is a symmetry-forbidden Raman transition;
however, the out-of-phase asymmetric azido vibration (υasym(N3))
and crystal packing give rise to the Raman-active asymmetric
vibrations. This also applies to the symmetrical azido stretching
vibration (υsym(N3)).T
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Six υasym(N3) bands were identiﬁed from the second derivative
ATR-FTIR spectrum of C1 and ﬁve for C1′ and C2 (Figure 4).
Such a splitting of bands is expected due to factor group splitting,
diﬀerent platinum−nitrogen (N3) and nitrogen−nitrogen (N3)
bond lengths and angles, in-phase and out-of-phase vibrations,
intermolecular hydrogen bonding, and longer distance inter-
actions. Platinum and other heavy metal azido compounds with
similar splitting of vibrations have been reported.61,62
As mentioned above, dissolution of C1 in water, followed
by evaporation prior to measurement (C1′) has no signiﬁcant
eﬀect on the pyridine vibrations but does eﬀect the hydroxido
vibration. Furthermore, diﬀerences in all azido vibrations
(υasym(N3), υsym(N3), δ(N3), and γ(N3)) are observed between
C1 and C1′ in both the ATR-FTIR and Raman spectra
(Table 1). Notably, changes in the intermolecular interactions
of C1 are most evident from the shifts in the main υasym(N3)
vibrations (C1 to C1′; 2051 to 2033 cm−1 IR, 2053 cm−1 to
2068/2053 cm−1 Raman) and the decrease in the number of
bands observed (six to ﬁve IR, four to two Raman).
Five υasym(N3) vibrations were observed by ATR-FTIR for
C2 (Figure 4). However, for C2 only one weak broad Raman
band is observed for υasym(N3) at 2057 cm
−1, whereas C1 and
C1′ have multiple bands of medium intensity as described
above. This could be due to the change in geometry going from
Pt(IV) to Pt(II), allowing for less dissymmetry and in turn
weaker Raman bands.
The symmetric azido vibration, υsym(N3), is observed in the
ATR-FTIR spectra at 1292/1271 cm−1 for C1 and 1294 cm−1
for C2, whereas the corresponding Raman bands are at
1291/1282 cm−1 (C1) and 1325/1298 cm−1 (C2). The ﬁrst
degenerate bending vibration, δ(N3), overlaps with the out-of-
plane pyridine bending vibration in the ATR-FTIR; γ(py)
{B1, 11}, δ(N3) for C1 (697/684 cm
−1) and C2 (696 cm−1).
The second azido bending vibration, γ(N3), is observed as
one strong band at 568 cm−1 in the SR-FIR spectrum of C2.
Notably, the asymmetry of C1 splits this band into two peaks at
584 and 573 cm−1.
At this stage, diﬀerences in the splitting of the azido vibra-
tions in the ATR-FTIR and Raman spectra arising from crystal
packing eﬀects cannot be ruled out. C1 crystallizes in an ortho-
rhombic system, Pbca, and contains eight formula units per unit
cell (Z = 8), allowing for factor group splitting. Furthermore,
Figure 3. ATR-FTIR spectra of C1, C2, C3 (solid) and C1′ (dissolution of C1 in water followed by evaporation prior to measurements).
Figure 4. ATR-FTIR spectra overlapped with the second derivative for C1 (solid), C2 (solid), and C1′ (dissolution of C1 in water followed by
evaporation prior to measurements) highlighting υasym(N3) changes going from C2 to C1 and the eﬀect of dissolution followed by evaporation of C1
prior to measurement (C1′).
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one azido ligand has a longer contact (2.630 Å) with an
oxygen of a neighboring complex.10 The crystal structure of C2
(monoclinic, I121, Z = 2) revealed disordered pyridines over
approximately two orientations.41 Additionally, C1 and C2
contain two trans-azido ligands, which allow for in-phase
and out-of-phase vibrations (see model of C1 in Figure 5).
The asymmetry of C1, observed in the crystal structure and
optimized structures, can give rise to IR active in-phase and
out-of-phase υasym(N3) vibrations as indicated by the DFT
calculations.
Metal−Ligand Vibrations. The SR-FIR spectra of C1, C2,
and C3 are illustrated in Figure 6. Many of the bands are highly
deﬁned due to the increased factor group splitting at 77 K and
the use of synchrotron radiation. The theoretical calculations
are in good agreement with the measured spectra, and multiple
bending vibrations accompany the majority of the bands (see
Supporting Information, Tables S4−S6). The main platinum−
ligand stretches and bending modes are discussed here.
Strong platinum-oxygen (OH) stretching bands are observed
for the asymmetric stretching vibration; υasym(HO−Pt−OH) at
545 and 541 cm−1, with multiple weak shoulders observed
in the SR-FIR spectra as well as one strong Raman band at
540 cm−1, corresponding to the symmetric stretching vibration
υsym(HO−Pt−OH). These assignments are in agreement with
a recent reinterpretation of the vibrational assignments for
cis,cis,trans-[Pt(NH3)2Cl2(OH)2], which reported stretching
vibrations for υasym(HO−Pt−OH) and υsym(HO−Pt−OH) at
575 and 559 cm−1, respectively.56,59 The splitting of multiple
bands by IR can be explained by the crystal structure of C1,
which contains eight formula units per unit cell. Furthermore,
one hydroxido hydrogen of C1 is involved in hydrogen bonding
to an oxygen (1.989 Å) on a neighboring complex, while the
other has a longer contact (2.630 Å) to the azido group of a
neighboring complex and its oxygen is involved in hydrogen
bonding to a hydrogen of a diﬀerent neighboring complex.10
The corresponding bending vibration, scr(HO−Pt−OH), was
matched to the 301 cm−1 band in the SR-FIR spectrum.
Four bands were identiﬁed in the SR-FIR spectrum of C1 for
the platinum−nitrogen (N3) asymmetric stretch, υasym(N3−Pt−N3)
at 417, 413, 407, and 395 cm−1, whereas two bands are observed
for C2 at 408 and 400 cm−1. C2 is known to crystallize with the
pyridines disordered over approximately two orientations;41 this
is well-reﬂected in the two well-deﬁned bands of equal intensity
separated by 8 cm−1. Separation between the respective bands
was also present in the theoretically predicted spectra of the
two S0 structures, C2−1 and C2−2. The calculated diﬀerence
from the M06-2X functional was 12 cm−1, whereas a smaller
diﬀerence of 2 cm−1 was obtained with the PBE functional.
As described in the azido vibration section, C1 crystallizes in an
orthorhombic system (Pbca, Z = 8) and has two diﬀerent azido
orientations relative to the platinum center. It also exhibits
intermolecular hydrogen bonding and longer distance inter-
actions, which contribute to this splitting of υasym(N3−Pt−N3).
Earlier IR spectroscopic studies on [Pt(N3)6]
2− and [Pt(N3)4]
2−
revealed that the υ(Pt−N3) occur at 410/400 cm−1 and
408/394 cm−1 respectively, in line with our results.62,63 A very
strong and narrow symmetric platinum−nitrogen (N3) stretch-
ing vibration, υsym(N3−Pt−N3), is observed for C1 and C1′ in the
Raman spectrum at 415 and 414 cm−1 (Figures 7, S6, and S7),
while only a medium intensity band at 406 cm−1 is observed
for C2. The increase in intensity going from C2 to C1 is most
likely related to the oxidation state of platinum and addition of
hydroxido ligands. Thus, changes to the geometry/oxidation state
of C1 upon irradiation can potentially be monitored by the
υsym(N3−Pt−N3) Raman vibration. However, in the case of C2
Figure 5. Visualization of the υasym(N3) in-phase (A) and υasym(N3)
out-of-phase (B) in a model of C1. M06-2X/cc-pVDZ for C, H, N,
and O and cc-pVDZ-PP44 with ECP for Pt using the CPCM with
water as solvent.
Figure 6. SR-FIR spectra of solid C1, C2, and C3 measured at 77 K.
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an unusually strong band is located at 269 cm−1 in the SR-FIR
spectrum, and it is well-separated from other vibrational modes.
An IR-active asymmetric platinum−nitrogen (py) stretch,
υasym(py−Pt−py), is predicted by both M06-2X (243 m) and
PBE (248 w) in combination with in-phase scissoring of
N3−Pt−N3; scr(N3−Pt−N3). Furthermore, the diazido Pt(II)
complex C2 adopts an unusual crystal packing, with a twofold
axis of symmetry, where the dihedral angle between platinum
and azide is −107° (Pt−N−N−N). The azido ligand is bent
with an internal NNN angle of 159°, with distances to three
pyridine hydrogens in neighboring complexes of 2.401, 2.524,
and 2.604 Å, which are in nearly the same plane (Table S2 and
Figure S12). This crystal packing would greatly enhance the
intensity of a vibration such as υasym(py−Pt−py) + scr(N3−
Pt−N3) in-phase (i.e., bending of Pt−N3 toward the elongating
Pt−py) as shown by the experimental values. The Pt(IV)
complex C1 and dichloride Pt(II) complex C3 do not show
such an enhancement in intensity, and their experimental
υasym(py−Pt−py) vibrations were matched by the results of
computation. The weak experimental band for C1 at 258 cm−1
corresponds well to a calculated vibration of υasym(py−Pt−py) +
scr(N3−Pt−N3) + rot(Pt−OH), whereas the weak sharp peak
present in the spectrum of C3 at 258 cm−1 matches the cal-
culated vibration for υasym(py−Pt−py).
Far-IR spectra of C3 have been previously reported and
correlate well with the SR-FIR spectra.64−66 Adams et al.64
observed bands at 343 (vs), 327 (sh), and 283 (vs) cm−1
related to Pt−Cl stretches, which match our observed bands at
346/342/339 (s), 324 (w), and 286 (s) cm−1. Some C3 bands
show slight asymmetric line shapes (Figure 6) compared to C1
and C2. This is due to more pronounced anomalous dispersion
in C3 compared to the other compounds, and therefore the
true maxima of these bands might be slightly shifted to longer
wavenumber values.67 Assignments were not discussed in detail
by Adams et al.;64 however, the results of computation allowed
the assignment of two diﬀerent asymmetric Pt−Cl stretch-
ing vibrations at 346/342/339 cm−1 (υasym(Cl−Pt−Cl), rot(py)
{A2, ωz} in-phase, in-phase) and 286 cm
−1 (υasym(Cl−Pt−Cl),
rot(py) {A2, ωz} in-phase, out-of-phase). These asymmetric
stretching vibrations are combination bands with in-phase
rotation of pyridine (rot(py) {A2, ωz} in-phase), which occur
in-phase and out-of-phase with one another, that is, dipole
change in one direction (in-phase) or opposite direction
(out-of-phase). The splitting of the υasym(Cl−Pt−Cl) vibration
at ∼346 cm−1 is indicative of intermolecular coupling and
hydrogen bonding, which is not reﬂected in the previously
reported crystal structure. The 324 cm−1 SR-FIR band of C3
coincides with the Raman band at 326 cm−1 and is assigned
as the symmetric Pt−Cl vibration; υsym(Cl−Pt−Cl). The two
bending vibrations, scr(Cl−Pt−Cl) and wag(Cl−Pt−Cl), were
matched to computed values of 169 and 126 cm−1.
Monitoring the Reactivity of C1. The vibrational spectra
described above revealed marker bands in the mid- and
far-IR regions, which might be used to monitor the photo-
decomposition and/or photoinduced biomolecular interactions
of the photoactive Pt(IV) diazido complex C1. The upper end
of the mid-IR region (4000−3000 cm−1) contains signature
vibrations for C1 consisting of the hydroxido stretching vibration,
υ(OH), at 3566/3571 cm−1 (IR/Raman) and several pyridine
stretching vibrations, υ(CH), between 3113 and 3009 cm−1.
Strong bands are observed for the asymmetric azido stretch,
υasym(N3) of C1 and C1′ at ∼2051−2017 cm−1, which are
separated by at least 200 cm−1 from vibrations associated with
natural molecules in biological samples.33 The lower end of
the mid-IR region (1600−600 cm−1) mainly consists of pyridine
vibrations, all of which were assigned individually, and the
symmetric azido stretches at 1271/1282 cm−1 (IR/Raman).
The Raman and ATR-FTIR analysis of C1 following dissolution
and evaporation of the solvent prior to measurement allows for
low-concentration photodecomposition studies, where similar
detailed vibrations as the solid compound are obtained (C1′
vs C1). Subtle inter- and intramolecular changes can result in
noticeable shifts of the pyridine vibrational bands, while the
azido and hydroxido stretches allow for the monitoring of the
release and/or stability in the mid-IR region. The SR-FIR and
Raman spectra show several strong and sharp platinum-ligand
vibrations in the far-IR region, most notably the asymmetric
and symmetric platinum−oxygen (OH) at 541/540 cm−1
(IRasym/Ramansym) and platinum−nitrogen (N3) vibrations at
413/415 cm−1 (IRasym/Ramansym). Interestingly, the very strong
Raman intensity of the Pt−N(N3) vibration, υsym(N3−Pt−N3),
proved to be related to the octahedral geometry of C1; thus,
changes in the geometry of C1 upon irradiation might be
directly reﬂected in a reduction in the intensity of this vibration.
Furthermore, photoinduced binding of C1 to biomolecular
targets can result in new platinum−ligand vibrations in the
far-IR region. This is where the high sensitivity and strong group
splitting of these platinum complexes by SR-FIR provides an
invaluable window to study metal−ligand vibrations in detail.
■ CONCLUSIONS
Individual ligand (pyridine, hydroxido, and azido) and Pt-ligand
vibrations for trans,trans,trans-[Pt(N3)2(OH)2(py)2] (C1), a
photoactivatable diazido Pt(IV) anticancer prodrug candidate,
have been obtained using ATR-FTIR, Raman, and SR-FIR
spectroscopies and assigned by way of comparison with two of
its synthetic precursors, trans-[Pt(N3)2(py)2] (C2) and trans-
[PtCl2(py)2] (C3). Synchrotron radiation allowed access to
highly deﬁned vibrational signatures in the far-IR range, which
are otherwise challenging to obtain. Most notable of these were
Figure 7. Normalized Raman spectra of C1 (solid), C2 (solid), and
C1′ (dissolution of C1 in water followed by evaporation prior to
measurements).
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the strong Pt−OH vibrations (ca. 540 cm−1) and the Pt−N3
vibrations (415−395 cm−1). These vibrations are also Raman-
active, with the Raman spectrum also revealing multiple
asymmetric azido stretching vibrations (2053−2018 cm−1).
DFT calculations were used to aid assignment of vibrational
modes, with theoretical predictions found to be consistent
with the experimental spectra. These vibrational data provide a
basis for elucidating the dependence of photodecomposition
and photoinduced biomolecular interactions of C1 and related
complexes on the nature of the ligand set in both the mid- and
far-IR regions.
■ EXPERIMENTAL SECTION
Materials. All reactions were performed under nitrogen atmospheres
using standard Schlenk techniques. K2PtCl4 (99%) was purchased
from Precious Metals Online. All other chemicals and solvents were
purchased from Sigma-Aldrich or BioScientiﬁc and used as received.
Synthesis. trans-[PtCl2(py)2] (C3) and trans-[Pt(N3)2(py)2] (C2)
were synthesized by published methods with characterization data in
agreement with those reported previously.10
trans,trans,trans-[Pt(N3)2(OH)2(py)2] (C1). The synthesis was
adapted from literature.10 It was performed under strict exclusion of
light, and puriﬁcation was performed without prolonged exposure to
light. trans-[Pt(N3)2(py)2] (0.25 g, 0.57 mmol) was suspended in 30%
H2O2 (20 mL) and stirred under nitrogen at 45 °C for 4 h resulting in
a bright yellow solution. The solution was ﬁltered while hot through
a 0.2 μm polytetraﬂuoroethylene syringe ﬁlter and concentrated to
2 mL under reduced pressure. The crude compound was obtained
by lyophilization and puriﬁed by column chromatography (silica, 40%
methanol, 60% ethyl acetate) Rf = 0.5, to give C1 > 95% pure by
HPLC (87 mg, 32%). Characterization data were in agreement with
those reported previously.10
Caution! No problems were encountered during this work; however,
heavy metal azides are known to be shock-sensitive detonators. Therefore,
it is essential that excessive pressure is not applied to platinum azido
compounds. Synthesis and all sample preparations were performed under
strict exclusion of light.
Instrumentation and Methods. Thermal Evaporation. A
modiﬁed LBS500 sputter system was used for thermal evaporation.
Plastic 96-well plates were coated with 100 nm silver by thermal
evaporation to remove the Raman signals of the well plate and aﬀord a
reﬂective surface.
High-Performance Liquid Chromatography. An Agilent 1260
Inﬁnity Analytical HPLC incorporated with an Inﬁnity diode array
detector (214/254 nm) was used with an Agilent Zorbax Eclipse Plus
C-18 Rapid Resolution column (95 Å, 3.5 μm, 100 × 4.6 mm).
ATR-FTIR Measurements. Spectra were acquired on a Bruker model
Equinox 55 FT-IR spectrometer ﬁtted with a N2-cooled mercury−
cadmium−telluride detector. A Specac golden gate diamond or a
Harrick silicon multiple reﬂection ATR accessory was used for spectral
acquisition. The silicon ATR accessory was used to acquire spectra of
samples in solvated state. For this purpose, 3 μL water solutions of C1
(2 mM) were deposited on the silicon ATR followed by evaporation
under a gentle N2 ﬂow resulting in a thin ﬁlm of compound for direct
measurement. The spectra were acquired with OPUS software 6.0.
ATR spectra were collected in the wavenumber range between 4000
and 400 cm−1 at a spectral resolution of 4 cm−1, and 50 interferograms
were coadded.
Raman Measurements. Raman spectra were acquired on a Renishaw
inVia instrument equipped with a Peltier-cooled CCD detector using a
modiﬁed Leica DM LM optical microscope and a 633 nm Coherent
HeNe laser. Two optical microscope objectives were used for spectral
acquisition: an Olympus ULWD MS Plan 50x/0.55 for 96-well plate
measurements and an Olympus SLMS Plans N 50x/0.35 for solid
samples. Solid samples were measured on standard microscopy slides,
and liquid samples (3−20 μL, 50 μM in Mili-Q water) were deposited
in a silver-coated 96-well plate followed by evaporation under a gentle
N2 ﬂow before measurement. The instrument was operated with WiRE
software, calibrated against a silicon wafer. Single scan Raman spectra
were collected in the wavenumber range between 4000 and 0 cm−1 with
an exposure time of 10 s. The laser power on the samples was kept
at ∼1 mW with a spectral resolution of ∼1 cm−1.
SR-FIR Measurements. SR-FIR spectra were measured at the
Terahertz/Far-IR beamline at the Australian Synchrotron (light source:
200 mA in top-up mode). Synchrotron radiation (SR) is an intrinsically
bright source and is 100−1000 times brighter than commercial thermal
(i.e., blackbody or globar) infrared sources.68 While SR is no more
powerful than a globar source, its eﬀective source size is smaller,
allowing for small beam-size measurements with high signal-to-noise
ratios, which in turn can oﬀer signiﬁcant advantages for studies of small
samples in the THz/far-IR region.69
Spectra were acquired on an IFS 125/HR Bruker FT spectrometer
equipped with a 6 μm multilayer Mylar beamsplitter, a Si Bolometer
detector, and an automated cryostat sample holder (ST-100, Janis
Research), which holds three samples. Small samples (0.5−1.5 mg)
were evenly spread on a 3 mm paraﬃn wax disk and pressed into
the paraﬃn by applying delicate hand pressure using a 3 mm die set
(Figure 8B). The 3 mm paraﬃn wax disks were prepared by pressing
roughly 20 mg of paraﬃn wax (Surgipath Paraplast, Leica Biosystems)
in a 7 mm die set using a hand press (PIKE Technologies, pressure
setting 6) followed by transferring the paraﬃn into a 3 mm die collar
(Figure 8A). Transmission spectra were collected between 700 and
0 cm−1 at a spectral resolution of 1 cm−1 using a 3.15 mm aperture and
64 interferograms coadded at room temperature (ca. 301 K) and 77 K.
Following this, a second measurement at room temperature was taken,
and no discernible diﬀerences between the room-temperature spectra
were observed.
Data Processing. Preprocessing of the spectral data was performed
in OPUS software 7.2 (Bruker Optics). SR-FIR spectra were averaged
(eight for C1 and four for C2 and C3) and transformed to absorbance
prior to concave rubber-band baseline correction and vector normali-
zation. Diamond ATR-FTIR spectra of solid/crystalline C1, C2, and
C3 exhibited anomalous dispersion (rapid changes to the refractive
index of a sample while scanning through an absorption peak)
resulting in asymmetric line shapes and shifts in absorption maxima67
(Figure S14A). These artifacts were identical within replicates, and six
spectra were ﬁrst averaged followed by extended ATR correction to
correct for these artifacts prior to concave rubber-band baseline correc-
tion and vector normalization. A detailed description of the extended
ATR correction is given in the Supporting Information. Diamond
and silicon ATR-FTIR spectra of C1′ did not exhibit these artifacts
(Figure S13), and averaged spectra (six) were only baseline-corrected
(concave rubber-band) and vector-normalized. Only vector-normalization
was applied to Raman spectra after an average was taken of six spectra.
Second derivatives were obtained using nine smoothing points.
Computational Details. DFT calculations were performed using
the Gaussian09 package70 with the Perdew−Burke−Ernzerhof exchange
correlation functional and Minnesota 06 Functional (M06-2X). A mixed
basis set is used where a cc-pVDZ basis set was used for carbon,
hydrogen, nitrogen, and oxygen and the cc-pVDZ-PP basis set44 with
eﬀective core potentials (ECP) for platinum. Geometry optimization of
Figure 8. SR-FIR sample holders; (A) paraﬃn blank; (B) paraﬃn
holding C1 (1 mg).
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the ground-state (S0) of C1, C2, and C3 were performed using the
conductor-like polarizable continuum model (CPCM) with water as
solvent to better describe the electrostatic interactions between platinum
and ligands.71−73 Gas-phase calculations were performed for compar-
ison. By allowing all parameters to relax, the calculations converged to
optimized geometries corresponding to true energy minima, as revealed
by the lack of imaginary values in the vibrational mode calculations.
A full conformation screening was performed on C1, C2, and C3 by
systematically changing all the dihedral angles for the respective
complexes until corresponding minima were attained. Ground-state
optimization of C1 resulted in four S0 geometries with PBE and M06-2X
exchange-correlation functionals, respectively. Ground-state optimization
of C2 resulted in seven S0 geometries each with PBE and M06-2X.
Likewise, one S0 geometry with PBE and two with M06-2X were
obtained for C3. Ground-state lowest energy geometries (S0) computed
by theoretical calculations using CPCM were compared to the previously
reported crystal structures, and closest matches from both PBE and
M06-2X were used to match experimental vibrational results. The calcu-
lated IR frequencies and intensities were exported from GaussView 5;74
IR peak half-width at half height: 4 cm−1, step size 1 and visualized using
OPUS software 7.2.
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